首页 | 本学科首页   官方微博 | 高级检索  
检索        

老年恶性肿瘤患者甲状腺功能状态及化学药物疗法对其的影响
引用本文:邹春华,黄涛金,谢勇久,林争,王绎,明华.老年恶性肿瘤患者甲状腺功能状态及化学药物疗法对其的影响[J].武警医学,2014(12):1225-1227.
作者姓名:邹春华  黄涛金  谢勇久  林争  王绎  明华
作者单位:武警四川总队成都医院肿瘤科,610041
摘    要:目的探讨老年恶性肿瘤患者的甲状腺功能状态及化学药物疗法(简称化疗)对其甲状腺功能的影响。方法选取2010-01至2014-02确诊的老年恶性肿瘤患者398例,并选择400例体检老年人群作为健康对照组,进行甲状腺激素(thyroid hormone,TH)和促甲状腺激素(thyroid stimulating hormone,TSH)水平测定。将激素水平正常,KPS(Karnofsky)评分〉60的老年恶性肿瘤患者分为:肿瘤治疗组132例,肿瘤对照组129例。两组年龄、KPS评分无统计学差异。肿瘤治疗组患者进行相应化疗,观察治疗前及治疗后6个月的TH和TSH水平,肿瘤对照组仅给予对症治疗,同期比较两组TH和TSH水平,分析化疗对老年恶性肿瘤患者甲状腺功能的影响。结果 398例老年恶性肿瘤患者的TH、TSH与健康对照组相比差异无统计学意义(P〉0.05)。肿瘤治疗组患者的TH、TSH与肿瘤对照组相比,TSH的差异存统计学意义(P〈0.05)。肿瘤治疗组中甲状腺功能减退(甲减)的比例为7.58%,亚临床型甲减的比例为23.48%。肿瘤对照组中甲减的比例为5.65%,亚临床甲减的比例为5.65%。两组比较,亚临床型甲减的发生率存在统计学差异(P〈0.05)。结论老年恶性肿瘤患者的甲状腺功能异常发生率与健康群体比较无统计学差异,化疗对老年恶性肿瘤患者的甲状腺功能有一定的影响。

关 键 词:恶性肿瘤  老年  甲状腺激素  甲状腺功能亢进  甲状腺功能减退

Thyroid functional status in aged patients with malignant tumors and relationship with chemotherapy
ZOU Chunhua,HUANG Taojin,XIE Yongjiu,LIN Zheng,WANG Yi,MING Hua.Thyroid functional status in aged patients with malignant tumors and relationship with chemotherapy[J].Medical Journal of the Chinese People's Armed Police Forces,2014(12):1225-1227.
Authors:ZOU Chunhua  HUANG Taojin  XIE Yongjiu  LIN Zheng  WANG Yi  MING Hua
Institution:(Department of Oncology, Chengdu Hospital of Sichuan Provincial Corps, Chinese People' s Armed Police Forces, Chengdu 610041 , China)
Abstract:Objective To study thyroid functional status of the aged patients with malignant tumors and the relationship between thyroid function with chemotherapy. Methods 398 aged patients with malignant tumors were recruited as the pathological group. At the same time,400 aged healthg subjects served as the control group. The thyroid hormones( thyroid hormone,TH),and thyrotropin( thyroid stimulating hormone,TSH) levels were measured. The thyroid function in the groups was analyzed and compared.When KPS score is over 60,the aged patients with malignant tumors in normal hormone levels were divided into the observation group( 132 cases) and the control group( 129 cases). Two groups had no significant difference in the age and KPS score. The patients in the observation group were treated by chemotherapy and TH and TSH levels observed before treatment and 6 moths post-treatment. The patients in the control group were given symptomatic treatment,TH and TSH levels were observed over the same period. We compared thyroid hormone and thyroid hormone levels and analyzed the relationship between thyroid function with chemotherapy in the aged patients with malignant tumor. Results The thyroid hormone and thyroid stimulating hormone in 398 aged patients with malignant tumor were compared with those in the healthy control group,the difference was not statistically significant( P〈0. 05). The aged patients with malignant tumors in normal hormone levels were divided into the observation group and the control group. In observation group the hypothyroidism( hypothyroidism) ratio was 7. 58%,the proportion of subclinical hypothyroidism was 23. 48%,hyperthyroidism( hyperthyroidism) ratio was 1. 51%,and subclinical hyperthyroidism ratio was 2. 27%. In control group,the proportion of hypothyroidism was 5. 65%,subclinical hypothyroidism ratio was 5. 65%,hyperthyroidism ratio was 1. 61% and subclinical hyperthyroidism ratio was3. 23%. In the observation group,the thyroid disease incidence rate was higher. Incidence of
Keywords:malignant tumor  the aged  thyroid hormone  hyperthyroidism  hypothyroidism
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号